Drug Prices
Valneva and Pfizer report Lyme disease antibody data
Children and adults have been treated using the Lyme disease antibody candidate VLA15…
Drug Prices
Drug Prices
Drug Prices
Respiratory vaccination candidate tested in German hospitals
Novel tuberculosis vaccine tested in a large phase 3 trial against severe respiratory…
Drug Prices
Eisai and Biogen present promising lecanemab study results
Eisai and Biogen present promising lecanemab study results Phase 3 research shows that…
Drug Prices
Otsuka receives vital Lupkynis MHRA authorisation
Therapy represents first oral calcineurin-inhibitor treatment for active lupus nephritis in adults Otsuka…
Drug Prices
Touchlight receives funding to develeop DNA vaccine platform
Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA…
Drug Prices
Immutep in clinical trail collaboration with Merck KGaA and Pfizer
Research will focus on eftilagimod alpha and avelumab for the treatment of urothelial…
Drug Prices
Almirall joins project to allow study participants to use trial data
Project involves 27 partners including patient associations, hospitals and universities Almirall – a…
Drug Prices
C4XD signs NRF2 Activator deal with AstraZeneca
C4XD will receive milestone payments worth up to $16m ahead of the first…
Drug Prices
Bristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation
Treatment involves adults with certain forms of advanced stomach and oesophageal cancer Bristol…
Drug Prices
Depressive therapy Spravato demonstrates superior efficacy
Research supports use of Spravato nasal spray in adults with major depressive disorder…
